Ginkgo Bioworks (DNA) Expected to Announce Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) is expected to release its earnings data after the market closes on Tuesday, February 25th. Analysts expect Ginkgo Bioworks to post earnings of ($1.45) per share and revenue of $44.43 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Ginkgo Bioworks Price Performance

DNA stock opened at $10.86 on Friday. The company has a fifty day moving average price of $11.48. Ginkgo Bioworks has a 12-month low of $5.26 and a 12-month high of $64.40. The stock has a market cap of $623.95 million, a P/E ratio of -0.83 and a beta of 1.16.

About Ginkgo Bioworks

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.